{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:20:47Z","timestamp":1787242847577,"version":"build-2736575974"},"reference-count":43,"publisher":"Aging and Disease","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2020]]},"DOI":"10.14336\/ad.2019.0801","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T17:14:11Z","timestamp":1580750051000},"page":"470","source":"Crossref","is-referenced-by-count":9,"title":["Molecular Aging Markers in Patients with Klinefelter Syndrome"],"prefix":"10.14336","volume":"11","author":[{"given":"Eva","family":"Pohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Muschal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kliesch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zitzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Rohayem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Gromoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Laurentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2019.0801-1","doi-asserted-by":"crossref","unstructured":"Baker GT, Sprott RL (1988). Biomarkers of aging. Exp Gerontol, 23:223-239.","DOI":"10.1016\/0531-5565(88)90025-3"},{"key":"key-10.14336\/AD.2019.0801-2","doi-asserted-by":"crossref","unstructured":"Horvath S, Raj K (2018). DNA methylation-based biomarkers and the epigenetic clock theory of aging. Nat Rev Genet, 19:371-384.","DOI":"10.1038\/s41576-018-0004-3"},{"key":"key-10.14336\/AD.2019.0801-3","doi-asserted-by":"crossref","unstructured":"Mather KA, Jorm AF, Parslow RAet al. (2011). Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci, 66:202-213.","DOI":"10.1093\/gerona\/glq180"},{"key":"key-10.14336\/AD.2019.0801-4","doi-asserted-by":"crossref","unstructured":"Hayflick L, Moorhead PS (1961). The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621.","DOI":"10.1016\/0014-4827(61)90192-6"},{"key":"key-10.14336\/AD.2019.0801-5","doi-asserted-by":"crossref","unstructured":"Olovnikov AM (1996). Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol, 31:443-448.","DOI":"10.1016\/0531-5565(96)00005-8"},{"key":"key-10.14336\/AD.2019.0801-6","doi-asserted-by":"crossref","unstructured":"Calado R, Young N (2012). Telomeres in disease. F1000 Med Rep, 4:8.","DOI":"10.3410\/M4-8"},{"key":"key-10.14336\/AD.2019.0801-7","doi-asserted-by":"crossref","unstructured":"Spyridopoulos I, Erben Y, Brummendorf THet al. (2008). Telomere gap between granulocytes and lymphocytes is a determinant for hematopoetic progenitor cell impairment in patients with previous myocardial infarction. Arterioscler Thromb Vasc Biol, 28:968-974.","DOI":"10.1161\/ATVBAHA.107.160846"},{"key":"key-10.14336\/AD.2019.0801-8","doi-asserted-by":"crossref","unstructured":"Yeh J-K, Wang C-Y (2016). Telomeres and Telomerase in Cardiovascular Diseases. Genes (Basel), 7:58","DOI":"10.3390\/genes7090058"},{"key":"key-10.14336\/AD.2019.0801-9","doi-asserted-by":"crossref","unstructured":"Zhang J, Rane G, Dai Xet al. (2016). Ageing and the telomere connection: An intimate relationship with inflammation. Ageing Res Rev, 25:55-69.","DOI":"10.1016\/j.arr.2015.11.006"},{"key":"key-10.14336\/AD.2019.0801-10","doi-asserted-by":"crossref","unstructured":"Kordinas V, Ioannidis A, Chatzipanagiotou S (2016). The Telomere\/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect? Genes (Basel), 7:60","DOI":"10.3390\/genes7090060"},{"key":"key-10.14336\/AD.2019.0801-11","doi-asserted-by":"crossref","unstructured":"Horvath S (2013). DNA methylation age of human tissues and cell types. Genome Biol, 14:R115.","DOI":"10.1186\/gb-2013-14-10-r115"},{"key":"key-10.14336\/AD.2019.0801-12","doi-asserted-by":"crossref","unstructured":"Hannum G, Guinney J, Zhao Let al. (2013). Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell, 49:359-367.","DOI":"10.1016\/j.molcel.2012.10.016"},{"key":"key-10.14336\/AD.2019.0801-13","doi-asserted-by":"crossref","unstructured":"Weidner CI, Lin Q, Koch CMet al. (2014). Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol, 15:R24.","DOI":"10.1186\/gb-2014-15-2-r24"},{"key":"key-10.14336\/AD.2019.0801-14","doi-asserted-by":"crossref","unstructured":"Marioni RE, Shah S, McRae AFet al. (2015). DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol, 16:25.","DOI":"10.1186\/s13059-015-0584-6"},{"key":"key-10.14336\/AD.2019.0801-15","doi-asserted-by":"crossref","unstructured":"Perna L, Zhang Y, Mons Uet al. (2016). Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort. Clin Epigenetics, 8:64.","DOI":"10.1186\/s13148-016-0228-z"},{"key":"key-10.14336\/AD.2019.0801-16","unstructured":"Chen BH, Marioni RE, Colicino Eet al. (2016). DNA methylation-based measures of biological age: meta-analysis predicting time to death. Aging (Albany NY), 8:1844-1865."},{"key":"key-10.14336\/AD.2019.0801-17","doi-asserted-by":"crossref","unstructured":"Christiansen L, Lenart A, Tan Qet al. (2016). DNA methylation age is associated with mortality in a longitudinal Danish twin study. Aging Cell 15:149-154.","DOI":"10.1111\/acel.12421"},{"key":"key-10.14336\/AD.2019.0801-18","doi-asserted-by":"crossref","unstructured":"Lin Q, Wagner W (2015). Epigenetic Aging Signatures Are Coherently Modified in Cancer. PLoS Genet, 11:e1005334.","DOI":"10.1371\/journal.pgen.1005334"},{"key":"key-10.14336\/AD.2019.0801-19","doi-asserted-by":"crossref","unstructured":"Soriano-T\u00e1rraga C, Giralt-Steinhauer E, Mola-Caminal Met al. (2016). Ischemic stroke patients are biologically older than their chronological age. Aging (Albany NY), 8:2655-2666.","DOI":"10.18632\/aging.101028"},{"key":"key-10.14336\/AD.2019.0801-20","doi-asserted-by":"crossref","unstructured":"Horvath S, Garagnani P, Bacalini MGet al. (2015). Accelerated epigenetic aging in Down syndrome. Aging, Cell 14:491-495.","DOI":"10.1111\/acel.12325"},{"key":"key-10.14336\/AD.2019.0801-21","doi-asserted-by":"crossref","unstructured":"Obeid R, H\u00fcbner U, Bodis Met al. (2016). Plasma Amyloid Beta 1-42 and DNA Methylation Pattern Predict Accelerated Aging in Young Subjects with Down Syndrome. Neuromolecular Med, 18:593-601.","DOI":"10.1007\/s12017-016-8413-y"},{"key":"key-10.14336\/AD.2019.0801-22","unstructured":"Nieschlag E (2013). Klinefelter syndrome: the commonest form of hypogonadism, but often overlooked or untreated. Dtsch Arztebl Int, 110:347-353."},{"key":"key-10.14336\/AD.2019.0801-23","doi-asserted-by":"crossref","unstructured":"Gravholt CH, Chang S, Wallentin Met al. (2018). Klinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology. Endocr Rev, 39:389-423.","DOI":"10.1210\/er.2017-00212"},{"key":"key-10.14336\/AD.2019.0801-24","doi-asserted-by":"crossref","unstructured":"Zitzmann M, Bongers R, Werler Set al. (2015). Gene expression patterns in relation to the clinical phenotype in Klinefelter syndrome. J Clin Endocrinol Metab, 100:E518-23.","DOI":"10.1210\/jc.2014-2780"},{"key":"key-10.14336\/AD.2019.0801-25","doi-asserted-by":"crossref","unstructured":"Bojesen A, Gravholt CH (2011). Morbidity and mortality in Klinefelter syndrome (47,XXY). Acta Paediatr, 100:807-813.","DOI":"10.1111\/j.1651-2227.2011.02274.x"},{"key":"key-10.14336\/AD.2019.0801-26","doi-asserted-by":"crossref","unstructured":"Bojesen A, Stochholm K, Juul Set al. (2011). Socioeconomic trajectories affect mortality in Klinefelter syndrome. J Clin Endocrinol Metab, 96:2098-2104.","DOI":"10.1210\/jc.2011-0367"},{"key":"key-10.14336\/AD.2019.0801-27","doi-asserted-by":"crossref","unstructured":"T\u00fcttelmann F, Luetjens CM, Nieschlag E (2006). Optimising workflow in andrology: a new electronic patient record and database. Asian J Androl 8:235-241.","DOI":"10.1111\/j.1745-7262.2006.00131.x"},{"key":"key-10.14336\/AD.2019.0801-28","doi-asserted-by":"crossref","unstructured":"Cawthon RM (2002). Telomere measurement by quantitative PCR. Nucleic Acids Res, 30:e47.","DOI":"10.1093\/nar\/30.10.e47"},{"key":"key-10.14336\/AD.2019.0801-29","doi-asserted-by":"crossref","unstructured":"Meyer A, Salewsky B, Buchmann Net al. (2016). Relative Leukocyte Telomere Length, Hematological Parameters and Anemia - Data from the Berlin Aging Study II (BASE-II). Gerontology, 62:330-336.","DOI":"10.1159\/000430950"},{"key":"key-10.14336\/AD.2019.0801-30","doi-asserted-by":"crossref","unstructured":"Pfaffl MW (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 29:e45.","DOI":"10.1093\/nar\/29.9.e45"},{"key":"key-10.14336\/AD.2019.0801-31","doi-asserted-by":"crossref","unstructured":"Englund A, Jonsson B, Zander CSet al. (2013). Changes in mortality and causes of death in the Swedish Down syndrome population. Am J Med Genet A, 161A:642-649.","DOI":"10.1002\/ajmg.a.35706"},{"key":"key-10.14336\/AD.2019.0801-32","unstructured":"Vaziri H, Sch\u00e4chter F, Uchida Iet al. (1993). Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Med Genet, 52:661-667."},{"key":"key-10.14336\/AD.2019.0801-33","doi-asserted-by":"crossref","unstructured":"Gruszecka A, Kopczy\u0144ski P, Cudzi\u0142o Det al. (2015). Telomere shortening in Down syndrome patients--when does it start? DNA Cell Biol, 34:412-417.","DOI":"10.1089\/dna.2014.2746"},{"key":"key-10.14336\/AD.2019.0801-34","doi-asserted-by":"crossref","unstructured":"Belling K, Russo F, Jensen ABet al. (2017). Klinefelter syndrome comorbidities linked to increased X chromosome gene dosage and altered protein interactome activity. Hum Mol Genet, 26:1219-1229.","DOI":"10.1093\/hmg\/ddx014"},{"key":"key-10.14336\/AD.2019.0801-35","doi-asserted-by":"crossref","unstructured":"Tanaka K, Nishide J, Okazaki Ket al. (1999). Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol Cell Biol, 19:8660-8672.","DOI":"10.1128\/MCB.19.12.8660"},{"key":"key-10.14336\/AD.2019.0801-36","doi-asserted-by":"crossref","unstructured":"Xhemalce B, Riising EM, Baumann Pet al. (2007). Role of SUMO in the dynamics of telomere maintenance in fission yeast. Proc Natl Acad Sci U S A, 104:893-898.","DOI":"10.1073\/pnas.0605442104"},{"key":"key-10.14336\/AD.2019.0801-37","doi-asserted-by":"crossref","unstructured":"Kveiborg M, Gravholt CH, Kassem M (2001). Evidence of a normal mean telomere fragment length in patients with Ullrich-Turner syndrome Eur J Hum Genet, 9:877-879.","DOI":"10.1038\/sj.ejhg.5200722"},{"key":"key-10.14336\/AD.2019.0801-38","doi-asserted-by":"crossref","unstructured":"Jylh\u00e4v\u00e4 J, Pedersen NL, H\u00e4gg S (2017). Biological Age Predictors. EbioMedicine, 21:29-36.","DOI":"10.1016\/j.ebiom.2017.03.046"},{"key":"key-10.14336\/AD.2019.0801-39","doi-asserted-by":"crossref","unstructured":"Ventura Ferreira MS, Crysandt M, Ziegler Pet al. (2017). Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia. Ann Hematol, 96:1457-1461.","DOI":"10.1007\/s00277-017-3049-z"},{"key":"key-10.14336\/AD.2019.0801-40","doi-asserted-by":"crossref","unstructured":"Steegenga WT, Boekschoten MV, Lute Cet al. (2014). Genome-wide age-related changes in DNA methylation and gene expression in human PBMCs. Age (Dordr), 36:9648.","DOI":"10.1007\/s11357-014-9648-x"},{"key":"key-10.14336\/AD.2019.0801-41","doi-asserted-by":"crossref","unstructured":"Vetter VM, Meyer A, Karbasiyan Met al. (2019). Epigenetic Clock and Relative Telomere Length Represent Largely Different Aspects of Aging in the Berlin Aging Study II (BASE-II). J Gerontol A Biol Sci Med Sci, 74:27-32.","DOI":"10.1093\/gerona\/gly184"},{"key":"key-10.14336\/AD.2019.0801-42","doi-asserted-by":"crossref","unstructured":"Belsky DW, Moffitt TE, Cohen AAet al. (2018). Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing? Am J Epidemiol 187:1220-1230.","DOI":"10.1093\/aje\/kwx346"},{"key":"key-10.14336\/AD.2019.0801-43","doi-asserted-by":"crossref","unstructured":"Kabacik S, Horvath S, Cohen Het al. (2018). Epigenetic ageing is distinct from senescence-mediated ageing and is not prevented by telomerase expression. Aging (Albany NY), 10:2800-2815.","DOI":"10.18632\/aging.101588"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/ad-0-0-0-2001271007-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T22:36:59Z","timestamp":1627511819000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2019.0801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2019.0801","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}